🇺🇸 FDA

Company profile · Sponsor

Livzon

Livzon Pharmaceutical Group

C5B3969 · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Livzon (C5B3969) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C5B3969
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. Recombinant SARS-CoV-2 fusion protein vaccine (V-01)

    Livzon

    COVID-19 Pandemic

    phase 3 mab active

    1 trial

  2. Recombinant SARS-CoV-2 Fusion Protein Vaccine

    Livzon

    COVID19

    phase 1 mab completed

    1 trial

Frequently asked questions

What is Livzon?

Livzon (C5B3969) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Livzon sponsor?

We track 2 ClinicalTrials.gov-linked programs for Livzon, including Recombinant SARS-CoV-2 fusion protein vaccine (V-01) and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Livzon company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.